Skip to main content
. 2019 Apr 8;18:122. doi: 10.1186/s12936-019-2755-5

Fig. 1.

Fig. 1

Cost-effective prioritization of LLINs and treatment. The average cost-effective scale-up of access to LLINs (blue bars) and coverage of treatment (red bars) for a low (baseline PfPr2-10: 10%), b medium (baseline PfPr2-10: 30%) and c high (baseline PfPr2-10: 60%) non-seasonal transmission settings. Outcomes are similar for the seasonal setting (Additional file 2: Figure S1). Coverage does not reach 100% in the low-transmission scenario as elimination is achieved